Phase III studies in the therapy of small cell lung cancer (SCLC) : a North Central Cancer Treatment Group (NCCTG) trial

Lung Cancer ◽

10.1016/0169-5002(94)91711-6 ◽

1994 ◽

Vol 10 ◽

pp. S338

Keyword(s):

Lung Cancer ◽

Treatment Group ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

North Central ◽

Phase Iii Studies

Download Full-text

Phase III studies in the therapy of small cell lung cancer (SCLC): A North Central Cancer Treatment Group (NCCTG) trial

Lung Cancer ◽

10.1016/0169-5002(91)91740-3 ◽

1991 ◽

Vol 7 ◽

pp. 106 ◽

Keyword(s):

Lung Cancer ◽

Treatment Group ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Small Cell Lung ◽

North Central ◽

Phase Iii Studies

Download Full-text

Bolus Versus Infusion Regimens of Etoposide and Cisplatin in Treatment of Non-Small Cell Lung Cancer: A Study of the North Central Cancer Treatment Group

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/82.24.1899 ◽

1990 ◽

Vol 82 (24) ◽

pp. 1899-1903 ◽

Author(s):

R. M. Goldberg ◽

J. R. Jett ◽

T. M. Therneau ◽

P. S. Johnson ◽

L. K. Tschetter ◽

...

Keyword(s):

Lung Cancer ◽

Treatment Group ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

North Central ◽

Download Full-text

Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222

Cancer Investigation ◽

10.3109/07357907.2010.535061 ◽

2011 ◽

Vol 29 (4) ◽

pp. 266-271 ◽

Author(s):

Heidi Mc Kean ◽

Philip J. Stella ◽

Shauna L. Hillman ◽

Kendrith M. Rowland ◽

Michael W. Cannon ◽

...

Keyword(s):

Lung Cancer ◽

Treatment Group ◽

Elderly Patients ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

North Central ◽

Therapeutic Decisions

Download Full-text

Prognostic importance of performance status (PS) in small cell lung cancer (SCLC): A North Central Cancer Treatment Group (NCCTG) investigation

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.19041 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19041-19041

Author(s):

N. R. Foster ◽

S. J. Mandrekar ◽

S. E. Schild ◽

G. D. Nelson ◽

K. M. Rowland Jr ◽

...

Keyword(s):

Lung Cancer ◽

Treatment Group ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell Lung ◽

North Central ◽

Prognostic Importance

Download Full-text

Incidence of bleeding and thrombosis among elderly patients (pts) undergoing systemic chemotherapy in advanced non-small cell lung cancer (NSCLC): An analysis of North Central Cancer Treatment Group (NCCTG) trials.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e18093 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e18093-e18093 ◽

Author(s):

Y. Qi ◽

G. K. Dy ◽

G. D. Nelson ◽

S. E. Schild ◽

S. J. Mandrekar ◽

...

Keyword(s):

Lung Cancer ◽

Treatment Group ◽

Elderly Patients ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Systemic Chemotherapy ◽

Small Cell Lung ◽

Download Full-text

Response rate and toxicity of pre-operative paclitaxel (P) and carboplatin (C) in patients with resectable non-small cell lung cancer: A North Central Cancer Treatment Group (NCCTG) Study

Lung Cancer ◽

10.1016/s0169-5002(00)80435-3 ◽

2000 ◽

Vol 29 (1) ◽

pp. 132 ◽

Author(s):

R.S Marks ◽

P.J Stella ◽

J.M Streitz ◽

M.R Mahoney ◽

C Deschamps

Keyword(s):

Lung Cancer ◽

Treatment Group ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Response Rate ◽

Small Cell Lung ◽

Download Full-text

Correlation Between Polymorphisms of the Reduced Folate Carrier Gene (SLC19A1) and Survival After Pemetrexed-Based Therapy in Non-small Cell Lung Cancer: A North Central Cancer Treatment Group-Based Exploratory Study

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181ec18c4 ◽

2010 ◽

Vol 5 (9) ◽

pp. 1346-1353 ◽

Author(s):

Araba A. Adjei ◽

Oreste E. Salavaggione ◽

Sumithra J. Mandrekar ◽

Grace K. Dy ◽

Katie L. Allen Ziegler ◽

...

Keyword(s):

Lung Cancer ◽

Treatment Group ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Exploratory Study ◽

Reduced Folate Carrier ◽

Small Cell Lung ◽

Download Full-text

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: Results of a North Central Cancer Treatment Group randomized clinical trial

Lung Cancer ◽

10.1016/0169-5002(94)90621-1 ◽

1994 ◽

Vol 11 (3-4) ◽

pp. 336

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Treatment Group ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Randomized Clinical Trial ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Download Full-text

Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: A study of the North Central Cancer Treatment Group

Lung Cancer ◽

10.1016/0169-5002(91)90068-h ◽

1991 ◽

Vol 7 (5) ◽

pp. 336

Keyword(s):

Lung Cancer ◽

Treatment Group ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

North Central ◽

Download Full-text

Comparison of progression-free survival (PFS) with best or confirmed response (BR, CR) as an endpoint for overall survival (OS) in advanced non small cell lung cancer (A-NSCLC): A North Central Cancer Treatment Group (NCCTG) investigation

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.8021 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 8021-8021 ◽

Author(s):

S. J. Mandrekar ◽

S. L. Hillman ◽

K. L. Allen Ziegler ◽

N. F. Reuter ◽

K. M. Rowland ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Treatment Group ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Progression Free Survival ◽

Small Cell Lung ◽

North Central ◽

Download Full-text